APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti Influenza Virus Chinese Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti Influenza Virus Chinese Medicine Market Analysis and Forecast 2026-2032

2 January 2026214 pages

Choose your research edition.

Industry ResearchAnti Influenza Virus Chinese Medicine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti Influenza Virus Chinese Medicine Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Anti Influenza Virus Chinese Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti Influenza Virus Chinese Medicine Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti Influenza Virus Chinese Medicine Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Anti Influenza Virus Chinese Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti Influenza Virus Chinese Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti Influenza Virus Chinese Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti Influenza Virus Chinese Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti Influenza Virus Chinese Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti Influenza Virus Chinese Medicine include China TCM, ZBD Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Zhejiang Conba Pharmaceutical, Changbaishan Pharmaceutical, Yunnan Baiyao, Yiling Pharmaceutical, Wuzhou Pharmaceutical and Tongrentang, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti Influenza Virus Chinese Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti Influenza Virus Chinese Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Anti Influenza Virus Chinese Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti Influenza Virus Chinese Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti Influenza Virus Chinese Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti Influenza Virus Chinese Medicine sales, projected growth trends, production technology, application and end-user industry.

Anti Influenza Virus Chinese Medicine Segment by Company

China TCM

ZBD Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Zhejiang Conba Pharmaceutical

Changbaishan Pharmaceutical

Yunnan Baiyao

Yiling Pharmaceutical

Wuzhou Pharmaceutical

Tongrentang

Yusheng Pharmaceutical

TASLY

Chase Sun Pharmaceutical

Green Valley Pharma

Livzon

Qingfeng Pharmaceutical Group

Jumpcan

CR SANJIU

Gerun Pharmaceutical

Fusen Pharmaceutical

Shineway Pharmaceutical

Harbin Pharmaceutical Group

Harbin Pharmaceutical Group

Guangzhou Pharmaceutical

Buchang Pharmaceutical

Anti Influenza Virus Chinese Medicine Segment by Type

Injection

Syrup

Aerosol

Oral Solution

Particles

Chewable Tablets

Capsule

Lozenges

Pills

Anti Influenza Virus Chinese Medicine Segment by Application

Adult

Children

Anti Influenza Virus Chinese Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti Influenza Virus Chinese Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti Influenza Virus Chinese Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti Influenza Virus Chinese Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti Influenza Virus Chinese Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti Influenza Virus Chinese Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti Influenza Virus Chinese Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti Influenza Virus Chinese Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Syrup Major Manufacturers Table 4. Aerosol Major Manufacturers Table 5. Oral Solution Major Manufacturers Table 6. Particles Major Manufacturers Table 7. Chewable Tablets Major Manufacturers Table 8. Capsule Major Manufacturers Table 9. Lozenges Major Manufacturers Table 10. Pills Major Manufacturers Table 11. Global Anti Influenza Virus Chinese Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Adult Major Manufacturers Table 13. Children Major Manufacturers Table 14. Anti Influenza Virus Chinese Medicine Industry Trends Table 15. Anti Influenza Virus Chinese Medicine Industry Drivers Table 16. Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges Table 17. Anti Influenza Virus Chinese Medicine Industry Restraints Table 18. Global Anti Influenza Virus Chinese Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2021-2026) Table 22. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2027-2032) Table 23. Global Anti Influenza Virus Chinese Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 24. Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (K Tons) Table 25. Global Anti Influenza Virus Chinese Medicine Sales by Region (2027-2032) & (K Tons) Table 26. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2021-2026) Table 27. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2027-2032) Table 28. Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Anti Influenza Virus Chinese Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2021-2026) Table 32. Global Anti Influenza Virus Chinese Medicine Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Anti Influenza Virus Chinese Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti Influenza Virus Chinese Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Anti Influenza Virus Chinese Medicine Manufacturers, Product Type & Application Table 36. Global Anti Influenza Virus Chinese Medicine Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti Influenza Virus Chinese Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti Influenza Virus Chinese Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2026) Table 43. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2027-2032) Table 44. Global Anti Influenza Virus Chinese Medicine Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 45. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 46. Global Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 47. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2026) Table 48. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2027-2032) Table 49. Global Anti Influenza Virus Chinese Medicine Price by Type (2021-2026) & (US$/Ton) Table 50. Global Anti Influenza Virus Chinese Medicine Price by Type (2027-2032) & (US$/Ton) Table 51. Global Anti Influenza Virus Chinese Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2026) Table 55. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2027-2032) Table 56. Global Anti Influenza Virus Chinese Medicine Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 57. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 58. Global Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 59. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2026) Table 60. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2027-2032) Table 61. Global Anti Influenza Virus Chinese Medicine Price by Application (2021-2026) & (US$/Ton) Table 62. Global Anti Influenza Virus Chinese Medicine Price by Application (2027-2032) & (US$/Ton) Table 63. China TCM Company Information Table 64. China TCM Business Overview Table 65. China TCM Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. China TCM Anti Influenza Virus Chinese Medicine Product Portfolio Table 67. China TCM Recent Development Table 68. ZBD Pharmaceutical Company Information Table 69. ZBD Pharmaceutical Business Overview Table 70. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 72. ZBD Pharmaceutical Recent Development Table 73. Zhejiang Kanglaite Pharmaceutical Company Information Table 74. Zhejiang Kanglaite Pharmaceutical Business Overview Table 75. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 77. Zhejiang Kanglaite Pharmaceutical Recent Development Table 78. Zhejiang Conba Pharmaceutical Company Information Table 79. Zhejiang Conba Pharmaceutical Business Overview Table 80. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 82. Zhejiang Conba Pharmaceutical Recent Development Table 83. Changbaishan Pharmaceutical Company Information Table 84. Changbaishan Pharmaceutical Business Overview Table 85. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 87. Changbaishan Pharmaceutical Recent Development Table 88. Yunnan Baiyao Company Information Table 89. Yunnan Baiyao Business Overview Table 90. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio Table 92. Yunnan Baiyao Recent Development Table 93. Yiling Pharmaceutical Company Information Table 94. Yiling Pharmaceutical Business Overview Table 95. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 97. Yiling Pharmaceutical Recent Development Table 98. Wuzhou Pharmaceutical Company Information Table 99. Wuzhou Pharmaceutical Business Overview Table 100. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 102. Wuzhou Pharmaceutical Recent Development Table 103. Tongrentang Company Information Table 104. Tongrentang Business Overview Table 105. Tongrentang Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio Table 107. Tongrentang Recent Development Table 108. Yusheng Pharmaceutical Company Information Table 109. Yusheng Pharmaceutical Business Overview Table 110. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 112. Yusheng Pharmaceutical Recent Development Table 113. TASLY Company Information Table 114. TASLY Business Overview Table 115. TASLY Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. TASLY Anti Influenza Virus Chinese Medicine Product Portfolio Table 117. TASLY Recent Development Table 118. Chase Sun Pharmaceutical Company Information Table 119. Chase Sun Pharmaceutical Business Overview Table 120. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 122. Chase Sun Pharmaceutical Recent Development Table 123. Green Valley Pharma Company Information Table 124. Green Valley Pharma Business Overview Table 125. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio Table 127. Green Valley Pharma Recent Development Table 128. Livzon Company Information Table 129. Livzon Business Overview Table 130. Livzon Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Livzon Anti Influenza Virus Chinese Medicine Product Portfolio Table 132. Livzon Recent Development Table 133. Qingfeng Pharmaceutical Group Company Information Table 134. Qingfeng Pharmaceutical Group Business Overview Table 135. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 137. Qingfeng Pharmaceutical Group Recent Development Table 138. Jumpcan Company Information Table 139. Jumpcan Business Overview Table 140. Jumpcan Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio Table 142. Jumpcan Recent Development Table 143. CR SANJIU Company Information Table 144. CR SANJIU Business Overview Table 145. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio Table 147. CR SANJIU Recent Development Table 148. Gerun Pharmaceutical Company Information Table 149. Gerun Pharmaceutical Business Overview Table 150. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 152. Gerun Pharmaceutical Recent Development Table 153. Fusen Pharmaceutical Company Information Table 154. Fusen Pharmaceutical Business Overview Table 155. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 156. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 157. Fusen Pharmaceutical Recent Development Table 158. Shineway Pharmaceutical Company Information Table 159. Shineway Pharmaceutical Business Overview Table 160. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 161. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 162. Shineway Pharmaceutical Recent Development Table 163. Harbin Pharmaceutical Group Company Information Table 164. Harbin Pharmaceutical Group Business Overview Table 165. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 166. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 167. Harbin Pharmaceutical Group Recent Development Table 168. Harbin Pharmaceutical Group Company Information Table 169. Harbin Pharmaceutical Group Business Overview Table 170. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 171. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 172. Harbin Pharmaceutical Group Recent Development Table 173. Guangzhou Pharmaceutical Company Information Table 174. Guangzhou Pharmaceutical Business Overview Table 175. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 176. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 177. Guangzhou Pharmaceutical Recent Development Table 178. Buchang Pharmaceutical Company Information Table 179. Buchang Pharmaceutical Business Overview Table 180. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 181. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 182. Buchang Pharmaceutical Recent Development Table 183. North America Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 184. North America Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 185. North America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 186. North America Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 187. North America Anti Influenza Virus Chinese Medicine Sales Price by Type (2021-2026) & (US$/Ton) Table 188. North America Anti Influenza Virus Chinese Medicine Sales Price by Type (2027-2032) & (US$/Ton) Table 189. North America Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 190. North America Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 191. North America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 192. North America Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 193. North America Anti Influenza Virus Chinese Medicine Sales Price by Application (2021-2026) & (US$/Ton) Table 194. North America Anti Influenza Virus Chinese Medicine Sales Price by Application (2027-2032) & (US$/Ton) Table 195. North America Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. North America Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. North America Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. North America Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 199. North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 200. North America Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 201. North America Anti Influenza Virus Chinese Medicine Sales Price by Country (2021-2026) & (US$/Ton) Table 202. North America Anti Influenza Virus Chinese Medicine Sales Price by Country (2027-2032) & (US$/Ton) Table 203. United States Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 204. Canada Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 205. Europe Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 206. Europe Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 207. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 208. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 209. Europe Anti Influenza Virus Chinese Medicine Sales Price by Type (2021-2026) & (US$/Ton) Table 210. Europe Anti Influenza Virus Chinese Medicine Sales Price by Type (2027-2032) & (US$/Ton) Table 211. Europe Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 212. Europe Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 213. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 214. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 215. Europe Anti Influenza Virus Chinese Medicine Sales Price by Application (2021-2026) & (US$/Ton) Table 216. Europe Anti Influenza Virus Chinese Medicine Sales Price by Application (2027-2032) & (US$/Ton) Table 217. Europe Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Europe Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. Europe Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 221. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 222. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 223. Europe Anti Influenza Virus Chinese Medicine Sales Price by Country (2021-2026) & (US$/Ton) Table 224. Europe Anti Influenza Virus Chinese Medicine Sales Price by Country (2027-2032) & (US$/Ton) Table 225. Germany Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 226. France Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 227. U.K. Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 228. Italy Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 229. Netherlands Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 230. China Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 231. China Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 232. China Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 233. China Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 234. China Anti Influenza Virus Chinese Medicine Sales Price by Type (2021-2026) & (US$/Ton) Table 235. China Anti Influenza Virus Chinese Medicine Sales Price by Type (2027-2032) & (US$/Ton) Table 236. China Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 237. China Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 238. China Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 239. China Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 240. China Anti Influenza Virus Chinese Medicine Sales Price by Application (2021-2026) & (US$/Ton) Table 241. China Anti Influenza Virus Chinese Medicine Sales Price by Application (2027-2032) & (US$/Ton) Table 242. Asia Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 243. Asia Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 244. Asia Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 245. Asia Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 246. Asia Anti Influenza Virus Chinese Medicine Sales Price by Type (2021-2026) & (US$/Ton) Table 247. Asia Anti Influenza Virus Chinese Medicine Sales Price by Type (2027-2032) & (US$/Ton) Table 248. Asia Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 249. Asia Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 250. Asia Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 251. Asia Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 252. Asia Anti Influenza Virus Chinese Medicine Sales Price by Application (2021-2026) & (US$/Ton) Table 253. Asia Anti Influenza Virus Chinese Medicine Sales Price by Application (2027-2032) & (US$/Ton) Table 254. Asia Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. Asia Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. Asia Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. Asia Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 258. Asia Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 259. Asia Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 260. Asia Anti Influenza Virus Chinese Medicine Sales Price by Country (2021-2026) & (US$/Ton) Table 261. Asia Anti Influenza Virus Chinese Medicine Sales Price by Country (2027-2032) & (US$/Ton) Table 262. Japan Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 263. South Korea Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 264. India Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 265. Australia Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 266. China Taiwan Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 267. Southeast Asia Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 268. SAMEA Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 269. SAMEA Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 270. SAMEA Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 271. SAMEA Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 272. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Type (2021-2026) & (US$/Ton) Table 273. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Type (2027-2032) & (US$/Ton) Table 274. SAMEA Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 275. SAMEA Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 276. SAMEA Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 277. SAMEA Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 278. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Application (2021-2026) & (US$/Ton) Table 279. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Application (2027-2032) & (US$/Ton) Table 280. SAMEA Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 281. SAMEA Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 282. SAMEA Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 283. SAMEA Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 284. SAMEA Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 285. SAMEA Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 286. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Country (2021-2026) & (US$/Ton) Table 287. SAMEA Anti Influenza Virus Chinese Medicine Sales Price by Country (2027-2032) & (US$/Ton) Table 288. Brazil Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 289. Argentina Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 290. Chile Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 291. Colombia Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 292. Peru Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 293. Saudi Arabia Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 294. Israel Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 295. UAE Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 296. Turkey Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 297. Iran Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 298. Egypt Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Table 299. Key Raw Materials Table 300. Raw Materials Key Suppliers Table 301. Anti Influenza Virus Chinese Medicine Distributors List Table 302. Anti Influenza Virus Chinese Medicine Customers List Table 303. Research Programs/Design for This Report Table 304. Authors List of This Report Table 305. Secondary Sources Table 306. Primary Sources List of Figures Figure 1. Anti Influenza Virus Chinese Medicine Image Figure 2. Global Anti Influenza Virus Chinese Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti Influenza Virus Chinese Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Syrup Image Figure 6. Aerosol Image Figure 7. Oral Solution Image Figure 8. Particles Image Figure 9. Chewable Tablets Image Figure 10. Capsule Image Figure 11. Lozenges Image Figure 12. Pills Image Figure 13. Global Anti Influenza Virus Chinese Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Anti Influenza Virus Chinese Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 15. Adult Image Figure 16. Children Image Figure 17. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Anti Influenza Virus Chinese Medicine Revenue (2021-2032) & (US$ Million) Figure 19. Global Anti Influenza Virus Chinese Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2021-2032) Figure 22. Global Anti Influenza Virus Chinese Medicine Sales (2021-2032) & (K Tons) Figure 23. Global Anti Influenza Virus Chinese Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 24. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Anti Influenza Virus Chinese Medicine Sales YoY (2021-2032) & (K Tons) Figure 26. Europe Anti Influenza Virus Chinese Medicine Sales YoY (2021-2032) & (K Tons) Figure 27. China Anti Influenza Virus Chinese Medicine Sales YoY (2021-2032) & (K Tons) Figure 28. Asia (Excluding China) Anti Influenza Virus Chinese Medicine Sales YoY (2021-2032) & (K Tons) Figure 29. South America, Middle East and Africa Anti Influenza Virus Chinese Medicine Sales YoY (2021-2032) & (K Tons) Figure 30. Global Anti Influenza Virus Chinese Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Anti Influenza Virus Chinese Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2032) Figure 36. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 37. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2032) Figure 39. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2032) Figure 42. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 43. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2032) Figure 45. North America Anti Influenza Virus Chinese Medicine Revenue Share by Type (2021-2032) Figure 46. North America Anti Influenza Virus Chinese Medicine Sales Share by Type (2021-2032) Figure 47. North America Anti Influenza Virus Chinese Medicine Revenue Share by Application

Scope & coverage.

Types
  • Injection
  • Syrup
  • Aerosol
  • Oral Solution
  • Particles
  • Chewable Tablets
  • Capsule
  • Lozenges
  • Pills
Applications
  • Adult
  • Children
Companies covered
  • China TCM
  • ZBD Pharmaceutical
  • Zhejiang Kanglaite Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • Changbaishan Pharmaceutical
  • Yunnan Baiyao
  • Yiling Pharmaceutical
  • Wuzhou Pharmaceutical
  • Tongrentang
  • Yusheng Pharmaceutical
  • TASLY
  • Chase Sun Pharmaceutical
  • Green Valley Pharma
  • Livzon
  • Qingfeng Pharmaceutical Group
  • Jumpcan
  • CR SANJIU
  • Gerun Pharmaceutical
  • Fusen Pharmaceutical
  • Shineway Pharmaceutical
  • Harbin Pharmaceutical Group
  • Harbin Pharmaceutical Group
  • Guangzhou Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti Influenza Virus Chinese Medicine Market by Type
  3. 1.2.1 Global Anti Influenza Virus Chinese Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Syrup
  6. 1.2.4 Aerosol
  7. 1.2.5 Oral Solution
  8. 1.2.6 Particles
  9. 1.2.7 Chewable Tablets
  10. 1.2.8 Capsule
  11. 1.2.9 Lozenges
  12. 1.2.10 Pills
  13. 1.3 Anti Influenza Virus Chinese Medicine Market by Application
  14. 1.3.1 Global Anti Influenza Virus Chinese Medicine Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Adult
  16. 1.3.3 Children
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Anti Influenza Virus Chinese Medicine Market Dynamics
  1. 2.1 Anti Influenza Virus Chinese Medicine Industry Trends
  2. 2.2 Anti Influenza Virus Chinese Medicine Industry Drivers
  3. 2.3 Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges
  4. 2.4 Anti Influenza Virus Chinese Medicine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti Influenza Virus Chinese Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region
  3. 3.2.1 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti Influenza Virus Chinese Medicine Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti Influenza Virus Chinese Medicine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti Influenza Virus Chinese Medicine Sales by Region
  9. 3.4.1 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026)
  11. 3.4.3 Global Anti Influenza Virus Chinese Medicine Sales by Region (2027-2032)
  12. 3.4.4 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturers
  2. 4.1.1 Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti Influenza Virus Chinese Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti Influenza Virus Chinese Medicine Sales by Manufacturers
  6. 4.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti Influenza Virus Chinese Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti Influenza Virus Chinese Medicine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti Influenza Virus Chinese Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti Influenza Virus Chinese Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti Influenza Virus Chinese Medicine Manufacturers, Product Type & Application
  13. 4.7 Global Anti Influenza Virus Chinese Medicine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti Influenza Virus Chinese Medicine Market CR5 and HHI
  16. 4.8.2 2025 Anti Influenza Virus Chinese Medicine Tier 1, Tier 2, and Tier 3
5 Anti Influenza Virus Chinese Medicine Market by Type
  1. 5.1 Global Anti Influenza Virus Chinese Medicine Revenue by Type
  2. 5.1.1 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti Influenza Virus Chinese Medicine Sales by Type
  6. 5.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti Influenza Virus Chinese Medicine Price by Type
6 Anti Influenza Virus Chinese Medicine Market by Application
  1. 6.1 Global Anti Influenza Virus Chinese Medicine Revenue by Application
  2. 6.1.1 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti Influenza Virus Chinese Medicine Sales by Application
  6. 6.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti Influenza Virus Chinese Medicine Price by Application
7 Company Profiles
  1. 7.1 China TCM
  2. 7.1.1 China TCM Company Information
  3. 7.1.2 China TCM Business Overview
  4. 7.1.3 China TCM Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China TCM Anti Influenza Virus Chinese Medicine Product Portfolio
  6. 7.1.5 China TCM Recent Developments
  7. 7.2 ZBD Pharmaceutical
  8. 7.2.1 ZBD Pharmaceutical Company Information
  9. 7.2.2 ZBD Pharmaceutical Business Overview
  10. 7.2.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  12. 7.2.5 ZBD Pharmaceutical Recent Developments
  13. 7.3 Zhejiang Kanglaite Pharmaceutical
  14. 7.3.1 Zhejiang Kanglaite Pharmaceutical Company Information
  15. 7.3.2 Zhejiang Kanglaite Pharmaceutical Business Overview
  16. 7.3.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  18. 7.3.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
  19. 7.4 Zhejiang Conba Pharmaceutical
  20. 7.4.1 Zhejiang Conba Pharmaceutical Company Information
  21. 7.4.2 Zhejiang Conba Pharmaceutical Business Overview
  22. 7.4.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  24. 7.4.5 Zhejiang Conba Pharmaceutical Recent Developments
  25. 7.5 Changbaishan Pharmaceutical
  26. 7.5.1 Changbaishan Pharmaceutical Company Information
  27. 7.5.2 Changbaishan Pharmaceutical Business Overview
  28. 7.5.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  30. 7.5.5 Changbaishan Pharmaceutical Recent Developments
  31. 7.6 Yunnan Baiyao
  32. 7.6.1 Yunnan Baiyao Company Information
  33. 7.6.2 Yunnan Baiyao Business Overview
  34. 7.6.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio
  36. 7.6.5 Yunnan Baiyao Recent Developments
  37. 7.7 Yiling Pharmaceutical
  38. 7.7.1 Yiling Pharmaceutical Company Information
  39. 7.7.2 Yiling Pharmaceutical Business Overview
  40. 7.7.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  42. 7.7.5 Yiling Pharmaceutical Recent Developments
  43. 7.8 Wuzhou Pharmaceutical
  44. 7.8.1 Wuzhou Pharmaceutical Company Information
  45. 7.8.2 Wuzhou Pharmaceutical Business Overview
  46. 7.8.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  48. 7.8.5 Wuzhou Pharmaceutical Recent Developments
  49. 7.9 Tongrentang
  50. 7.9.1 Tongrentang Company Information
  51. 7.9.2 Tongrentang Business Overview
  52. 7.9.3 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio
  54. 7.9.5 Tongrentang Recent Developments
  55. 7.10 Yusheng Pharmaceutical
  56. 7.10.1 Yusheng Pharmaceutical Company Information
  57. 7.10.2 Yusheng Pharmaceutical Business Overview
  58. 7.10.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  60. 7.10.5 Yusheng Pharmaceutical Recent Developments
  61. 7.11 TASLY
  62. 7.11.1 TASLY Company Information
  63. 7.11.2 TASLY Business Overview
  64. 7.11.3 TASLY Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 TASLY Anti Influenza Virus Chinese Medicine Product Portfolio
  66. 7.11.5 TASLY Recent Developments
  67. 7.12 Chase Sun Pharmaceutical
  68. 7.12.1 Chase Sun Pharmaceutical Company Information
  69. 7.12.2 Chase Sun Pharmaceutical Business Overview
  70. 7.12.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  72. 7.12.5 Chase Sun Pharmaceutical Recent Developments
  73. 7.13 Green Valley Pharma
  74. 7.13.1 Green Valley Pharma Company Information
  75. 7.13.2 Green Valley Pharma Business Overview
  76. 7.13.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio
  78. 7.13.5 Green Valley Pharma Recent Developments
  79. 7.14 Livzon
  80. 7.14.1 Livzon Company Information
  81. 7.14.2 Livzon Business Overview
  82. 7.14.3 Livzon Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Livzon Anti Influenza Virus Chinese Medicine Product Portfolio
  84. 7.14.5 Livzon Recent Developments
  85. 7.15 Qingfeng Pharmaceutical Group
  86. 7.15.1 Qingfeng Pharmaceutical Group Company Information
  87. 7.15.2 Qingfeng Pharmaceutical Group Business Overview
  88. 7.15.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  90. 7.15.5 Qingfeng Pharmaceutical Group Recent Developments
  91. 7.16 Jumpcan
  92. 7.16.1 Jumpcan Company Information
  93. 7.16.2 Jumpcan Business Overview
  94. 7.16.3 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio
  96. 7.16.5 Jumpcan Recent Developments
  97. 7.17 CR SANJIU
  98. 7.17.1 CR SANJIU Company Information
  99. 7.17.2 CR SANJIU Business Overview
  100. 7.17.3 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio
  102. 7.17.5 CR SANJIU Recent Developments
  103. 7.18 Gerun Pharmaceutical
  104. 7.18.1 Gerun Pharmaceutical Company Information
  105. 7.18.2 Gerun Pharmaceutical Business Overview
  106. 7.18.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  108. 7.18.5 Gerun Pharmaceutical Recent Developments
  109. 7.19 Fusen Pharmaceutical
  110. 7.19.1 Fusen Pharmaceutical Company Information
  111. 7.19.2 Fusen Pharmaceutical Business Overview
  112. 7.19.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  114. 7.19.5 Fusen Pharmaceutical Recent Developments
  115. 7.20 Shineway Pharmaceutical
  116. 7.20.1 Shineway Pharmaceutical Company Information
  117. 7.20.2 Shineway Pharmaceutical Business Overview
  118. 7.20.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  120. 7.20.5 Shineway Pharmaceutical Recent Developments
  121. 7.21 Harbin Pharmaceutical Group
  122. 7.21.1 Harbin Pharmaceutical Group Company Information
  123. 7.21.2 Harbin Pharmaceutical Group Business Overview
  124. 7.21.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  126. 7.21.5 Harbin Pharmaceutical Group Recent Developments
  127. 7.22 Harbin Pharmaceutical Group
  128. 7.22.1 Harbin Pharmaceutical Group Company Information
  129. 7.22.2 Harbin Pharmaceutical Group Business Overview
  130. 7.22.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  132. 7.22.5 Harbin Pharmaceutical Group Recent Developments
  133. 7.23 Guangzhou Pharmaceutical
  134. 7.23.1 Guangzhou Pharmaceutical Company Information
  135. 7.23.2 Guangzhou Pharmaceutical Business Overview
  136. 7.23.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  138. 7.23.5 Guangzhou Pharmaceutical Recent Developments
  139. 7.24 Buchang Pharmaceutical
  140. 7.24.1 Buchang Pharmaceutical Company Information
  141. 7.24.2 Buchang Pharmaceutical Business Overview
  142. 7.24.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  144. 7.24.5 Buchang Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Anti Influenza Virus Chinese Medicine Market Size by Type
  2. 8.1.1 North America Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  4. 8.1.3 North America Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
  5. 8.2 North America Anti Influenza Virus Chinese Medicine Market Size by Application
  6. 8.2.1 North America Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  8. 8.2.3 North America Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
  9. 8.3 North America Anti Influenza Virus Chinese Medicine Market Size by Country
  10. 8.3.1 North America Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti Influenza Virus Chinese Medicine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Anti Influenza Virus Chinese Medicine Market Size by Type
  2. 9.1.1 Europe Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
  5. 9.2 Europe Anti Influenza Virus Chinese Medicine Market Size by Application
  6. 9.2.1 Europe Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
  9. 9.3 Europe Anti Influenza Virus Chinese Medicine Market Size by Country
  10. 9.3.1 Europe Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti Influenza Virus Chinese Medicine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Anti Influenza Virus Chinese Medicine Market Size by Type
  2. 10.1.1 China Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  3. 10.1.2 China Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  4. 10.1.3 China Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
  5. 10.2 China Anti Influenza Virus Chinese Medicine Market Size by Application
  6. 10.2.1 China Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  7. 10.2.2 China Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  8. 10.2.3 China Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti Influenza Virus Chinese Medicine Market Size by Type
  2. 11.1.1 Asia Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
  5. 11.2 Asia Anti Influenza Virus Chinese Medicine Market Size by Application
  6. 11.2.1 Asia Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
  9. 11.3 Asia Anti Influenza Virus Chinese Medicine Market Size by Country
  10. 11.3.1 Asia Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti Influenza Virus Chinese Medicine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti Influenza Virus Chinese Medicine Market Size by Type
  2. 12.1.1 SAMEA Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
  5. 12.2 SAMEA Anti Influenza Virus Chinese Medicine Market Size by Application
  6. 12.2.1 SAMEA Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
  9. 12.3 SAMEA Anti Influenza Virus Chinese Medicine Market Size by Country
  10. 12.3.1 SAMEA Anti Influenza Virus Chinese Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti Influenza Virus Chinese Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti Influenza Virus Chinese Medicine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti Influenza Virus Chinese Medicine Value Chain Analysis
  2. 13.1.1 Anti Influenza Virus Chinese Medicine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti Influenza Virus Chinese Medicine Production Mode & Process
  6. 13.2 Anti Influenza Virus Chinese Medicine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti Influenza Virus Chinese Medicine Distributors
  9. 13.2.3 Anti Influenza Virus Chinese Medicine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst